Current evidence in high throughput ultrafiltration toward the purification of monoclonal antibodies (mAbs) and biotechnological protein-type molecules
- 19 September 2021
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Biotechnology
- Vol. 42 (6) , 827-837
Abstract
Pressure-driven membrane-based technologies, such as microfiltration (MF), ultrafiltration (UF), and nanofiltration (NF), have been successfully implemented in recovering different types of biomolecules and high-value-added compounds from various streams. Especially, UF membranes meet the requirements for separating specific bioproducts in downstream processes, e.g. monoclonal antibodies (mAbs), which are recognized as proteins produced mainly by plasma cells. According to the importance and functionality of the mAbs, their recovery is a current challenge with these bioseparations. Nevertheless, mAbs recovery using UF-assisted processes has been smartly performed over the last decade. To the best of our knowledge, there are no reviews of the reported developments using UF technology toward mAbs separation. Therefore, the goal of this paper is to collect and elucidate ongoing research studies implemented for the featured separation of mAbs and other biotechnological protein-type molecules (e.g. adenovirus serotype, extracellular vesicles, red fluorescent protein, cyanovirin-N, among others) via ultrafiltration-aided systems. The literature evidence (e.g. research papers, patents, etc.) has been analyzed and discussed according to the purpose of the study. Importantly, the relevant findings and novel approaches are discussed in detail. To finalize this document, the advantages, drawbacks, and guidelines in applying membrane-based techniques for such a recovery are presented.Keywords
Funding Information
- School of Engineering and Science
- FEMSA Biotechnology Center (0020209I13)
- Polish National Agency for Academic Exchange (PPN/ULM/2020/1/00005/U/00001)
This publication has 57 references indexed in Scilit:
- Membranes for Environmentally Friendly Energy ProcessesMembranes, 2012
- Refolding Technology for scFv Using a New Detergent, N-Lauroyl-L-glutamate and ArginineAntibodies, 2012
- Recovery and purification process development for monoclonal antibody productionmAbs, 2010
- Liquid high concentration IgG1 antibody formulations by precipitationJournal of Pharmaceutical Sciences, 2009
- Effective Antibody Production by Reusing Culture Medium Previously Used in Antibody PurificationBioscience, Biotechnology, and Biochemistry, 2009
- Application of aqueous two-phase systems to antibody purification: A multi-stage approachJournal of Biotechnology, 2009
- Bioprocess membrane technologyJournal of Membrane Science, 2007
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Challenges in the development of high protein concentration formulationsJournal of Pharmaceutical Sciences, 2004
- Re-use of spent cell culture medium in pilot scale and rapid preparative purification with membrane chromatographyJournal of Biotechnology, 1994